Tagworks Pharmaceuticals
Nijmegen, NL · 2 known investors
Tagworks Pharmaceuticals develops a controlled drug-release technology platform using click chemistry to enable targeted activation of antibody-drug conjugates and immunomodulators in tumors. The company aims to expand ADC therapy options for cancer patients by targeting non-internalizing receptors and improving therapeutic efficacy.